R Margolese
- Cancer Research top 10%
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Genetics
- Co-authors
- Norman WolmarkCarol RedmondB. FisherCarl M. SutherlandD. L. WickerhamN V DimitrovS Legault-PoissonEdwin R. Fisher
- Topics
- Breast Cancer Treatment Studies (4 papers)Cancer Treatment and Pharmacology (4 papers)Glycosylation and Glycoproteins Research (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
R Margolese
10 papers receiving 385 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 262
- Oncology 249
- Pathology and Forensic Medicine 115
- Pulmonary and Respiratory Medicine 85
- Genetics 49
Countries citing papers authored by R Margolese
This map shows the geographic impact of R Margolese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Margolese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Margolese more than expected).
Fields of papers citing papers by R Margolese
This network shows the impact of papers produced by R Margolese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Margolese. The network helps show where R Margolese may publish in the future.
Co-authorship network of co-authors of R Margolese
This figure shows the co-authorship network connecting the top 25 collaborators of R Margolese. A scholar is included among the top collaborators of R Margolese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Margolese. R Margolese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy? | 1 |
| 3 | 305 | |
| 4 | 7 | |
| 5 | Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer. | 6 |
| 6 | Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer. | 2 |
| 7 | 54 | |
| 8 | Pharmacology and toxicity of Ip streptozocin in ovarian cancer: a case report. | 3 |
| 9 | Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. | 6 |
| 10 | Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. | 28 |
About R Margolese
R Margolese is a scholar working on Cancer Research, Otorhinolaryngology and Oncology, having authored 10 papers that have together received 416 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (262 citations), Oncology (249 citations) and Pathology and Forensic Medicine (115 citations). R Margolese has collaborated with scholars based in United States and Canada. Frequent co-authors include Norman Wolmark, Carol Redmond, B. Fisher, Carl M. Sutherland, D. L. Wickerham, N V Dimitrov, S Legault-Poisson, Edwin R. Fisher, David M. J. S. Bowman and Clemens D. Cohen. Their work appears in journals such as New England Journal of Medicine, British Journal of Cancer and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.